International litigation support provider UBIC Inc. has entered into a partnership with M3 Inc. to develop services through artificial intelligence (AI) technology to be used in the health care and pharmaceuticals industries.
To begin, M3 subsidiary Mediscience Planning Inc. and UBIC Medical will develop the first AI-based pharmacovigilance support service in Japan. MPI will serve as a contract research organization.
The goal of the M3-UBIC partnership is to provide high-quality services that will lead to increased safety in pharmaceuticals. The two companies might also work together to develop an array of services in health care and pharmaceuticals using AI-based data analysis.
For more information about UBIC, contact usinfo@ubicna.com or visit www.ubic-global.com.
UBIC, M3 partnering to develop AI technology for health care
Alerts Sign-up